Cargando…

Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls

BACKGROUND: Shiga toxin (Stx)-producing Escherichia coli (STEC) infection is associated with hemolytic uremic syndrome (HUS), the main cause of acute renal failure in early childhood. Stx is essential in the pathogenesis of HUS, which has been mostly related to Stx2-producing isolates. Very limited...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guirro, Mirian, Piazza, Roxane Maria Fontes, de Souza, Renato Lopes, Guth, Beatriz Ernestina Cabilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060089/ https://www.ncbi.nlm.nih.gov/pubmed/24919599 http://dx.doi.org/10.1186/1471-2334-14-320

Ejemplares similares

First Shiga Toxin-Producing Escherichia coli Isolate from a Patient with Hemolytic Uremic Syndrome, Brazil
por: Guth, Beatriz Ernestina C., et al.
Publicado: (2002)

Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)
por: Mejías, Maria P., et al.
Publicado: (2016)

Hemolytic Uremic Syndrome in Pediatric Intensive Care Units in São Paulo, Brazil
por: de Souza, Renato Lopes, et al.
Publicado: (2011)

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Development and Characterization of Recombinant Antibody Fragments That Recognize and Neutralize In Vitro Stx2 Toxin from Shiga Toxin-Producing Escherichia coli
por: Luz, Daniela, et al.
Publicado: (2015)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody
por: Luz, Daniela, et al.
Publicado: (2021)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
por: Petruzziello-Pellegrini, Tania N, et al.
Publicado: (2013)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Shiga Toxin (Stx) Type 1a Reduces the Oral Toxicity of Stx Type 2a
por: Russo, Lisa M., et al.
Publicado: (2016)

Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized In Vivo, Leading to Production of Biologically Active Stx2
por: Bentancor, Leticia V., et al.
Publicado: (2013)

Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin
por: Bunger, Joshua C., et al.
Publicado: (2015)

Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
por: Neu, Charles, et al.
Publicado: (2023)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

Analysis Shiga Toxin-Encoding Bacteriophage in a Rare Strain of Shiga Toxin-Producing Escherichia coli O157:H7 stx2a/stx2c
por: Greig, David R., et al.
Publicado: (2020)

Shiga Toxin, Stx2e, Influences the Activity of Porcine Lymphocytes In Vitro
por: Sperling, Daniel, et al.
Publicado: (2023)

Differences in the Shiga Toxin (Stx) 2a Phage Regulatory Switch Region Influence Stx2 Localization and Virulence of Stx-Producing Escherichia coli in Mice
por: Atitkar, Rama R., et al.
Publicado: (2023)

Dynamic Gene Network Analysis of Caco-2 Cell Response to Shiga Toxin-Producing Escherichia coli-Associated Hemolytic–Uremic Syndrome
por: Bando, Silvia Y., et al.
Publicado: (2019)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Identification and Characterization of ten Escherichia coli Strains Encoding Novel Shiga Toxin 2 Subtypes, Stx2n as Well as Stx2j, Stx2m, and Stx2o, in the United States
por: Lindsey, Rebecca L., et al.
Publicado: (2023)

Prevalence and distribution of the stx(1), stx(2) genes in Shiga toxin producing E. coli (STEC) isolates from cattle
por: Tahamtan, Y, et al.
Publicado: (2010)

Shiga Toxin (Stx) Type 1a and Stx2a Translocate through a Three-Layer Intestinal Model
por: Bova, Rebecca A., et al.
Publicado: (2023)

Structural and Functional Characterization of Stx2k, a New Subtype of Shiga Toxin 2
por: Hughes, Anna C., et al.
Publicado: (2019)

Hemolytic Uremic Syndrome Associated with Escherichia coli O8:H19 and Shiga Toxin 2f Gene
por: Friesema, Ingrid H.M., et al.
Publicado: (2015)

Switching Shiga Toxin (Stx) Type from Stx2d to Stx2a but Not Stx2c Alters Virulence of Stx-Producing Escherichia coli (STEC) Strain B2F1 in Streptomycin (Str)-Treated Mice
por: McNichol, Beth A., et al.
Publicado: (2021)

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000
por: Tozzi, Alberto E., et al.
Publicado: (2003)

Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome
por: Detzner, Johanna, et al.
Publicado: (2020)

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania
por: Falup-Pecurariu, Oana, et al.
Publicado: (2019)

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome
por: Wijnsma, Kioa L., et al.
Publicado: (2020)

Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden
por: Hua, Ying, et al.
Publicado: (2021)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
por: Travert, Benoit, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report
por: Rigamonti, Elia, et al.
Publicado: (2022)

New High-Affinity Monoclonal Antibodies against Shiga Toxin 1 Facilitate the Detection of Hybrid Stx1/Stx2 In Vivo
por: Skinner, Craig, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jn1bnbhmovtk5trsru3mit72qt